VIVUS 3.75/23 (Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg)
Generic Name: phentermine/topiramate
Pill with imprint VIVUS 3.75/23 is Purple, Capsule-shape and has been identified as Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg. It is supplied by Vivus, Inc..
Qsymia is used in the treatment of obesity; weight loss and belongs to the drug class anorexiants. Not for use in pregnancy. Qsymia phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for VIVUS 3.75/23
Qsymia
- Generic Name:
- phentermine/topiramate
- Imprint:
- VIVUS 3.75/23
- Strength:
- phentermine hydrochloride 3.75 mg (base) / topiramate extended-release 23 mg
- Color:
- Purple
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Anorexiants
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- 4 - Some potential for abuse
- Labeler / Supplier:
- Vivus, Inc.
- Inactive Ingredients:
- sucrose
corn starch
microcrystalline cellulose
ethylcelluloses
povidone k30
gelatin
magnesium silicate
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
Note: Inactive ingredients may vary.
Submitted by: pillstress
More about Qsymia (phentermine / topiramate)
- Qsymia Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 491 Reviews
- Drug class: anorexiants
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
